Ciprofibrate is primarily used in the treatment of hyperlipidemia, a condition characterized by abnormally high levels of lipids in the blood. It works by lowering triglycerides and cholesterol, thereby reducing the risk of cardiovascular diseases such as heart attacks and strokes. The drug is often prescribed when lifestyle changes, such as diet and exercise, are insufficient to control lipid levels. It is particularly effective in patients with mixed hyperlipidemia, where both cholesterol and triglyceride levels are elevated. Additionally, ciprofibrate may be used in combination with other lipid-lowering agents for enhanced efficacy. It is important for patients to undergo regular monitoring of liver function and lipid profiles while on this medication, as it can affect liver enzymes and lipid metabolism. Overall, ciprofibrate plays a crucial role in managing lipid disorders and improving cardiovascular health.